Taking the lead: Sunnova Energy International Inc (NOVA)

With 7.5 million shares changed hands, the volume of the stock remained lighter than its average volume of 9.19 million shares. During the session, the Solar company that operates in wider Technology sector, reached to the highest price of $6.27 whereas the lowest price it dropped to was $5.54. The 52-week range on NOVA shows that it touched its highest point at $24.56 and its lowest point at $3.80 during that stretch. It currently has a 1-year price target of $17.20. Beta for the stock currently stands at 2.08.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NOVA was down-trending over the past week, with a drop of -2.07%, but this was down by -22.12% over a month. Three-month performance dropped to -64.25% while six-month performance fell -45.27%. The stock lost -59.27% in the past year, while it has lost -62.82% so far this year. A look at the trailing 12-month EPS for NOVA yields -3.51 with Next year EPS estimates of -2.30. For the next quarter, that number is -0.81. This implies an EPS growth rate of 26.94% for this year and 10.82% for next year. EPS is expected to decline by -14.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -17.44%.

Float and Shares Shorts:

At present, 122.47 million NOVA shares are outstanding with a float of 105.94 million shares on hand for trading. On Mar 15, 2024, short shares totaled 36.13 million, which was 29.49% higher than short shares on Feb 15, 2024. In addition to NVAX as the firm’s Novavax, Inc., IOVA serves as its Iovance Biotherapeutics, Inc.

Institutional Ownership:

Through their ownership of 132.36% of NOVA’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NOVA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.